ISSN 1977-091X

Official Journal

of the European Union

C 144
European flag  

English edition

Information and Notices

Volume 65
31 March 2022

Contents

page

 

IV   Notices

 

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

 

European Commission

2022/C 144/01

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2022 to 28 February 2022(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

1

EN

 

IV Notices

NOTICES FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

31.3.2022   

EN

Official Journal of the European Union

C 144/1

Summary of European Union decisions on marketing authorisations in respect of medicinal products from 1 February 2022 to 28 February 2022

(Published pursuant to Article 13 or Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council (1))

(2022/C 144/01)

—   Issuing of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

INN (International Non-Proprietary Name)

Holder of the marketing authorisation

Number of the entry in the Community Register

Pharmaceutical form

ATC code (Anatomical Therapeutic Chemical Code)

Date of notification

14.2.2022

Apexxnar

pneumococcal polysaccharide conjugate vaccine (20-valent, adsorbed)

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België

EU/1/21/1612

Suspension for injection

J07AL02

15.2.2022

14.2.2022

Ngenla

somatrogon

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België

EU/1/21/1617

Solution for injection

Pending

15.2.2022

14.2.2022

OKEDI

risperidone

Laboratorios Farmacéuticos Rovi, S.A.

Julián Camarillo 35, 28037 Madrid, España

EU/1/21/1621

Powder and solvent for prolonged-release suspension for injection

N05AX08

15.2.2022

14.2.2022

Oxbryta

voxelotor

Global Blood Therapeutics Netherlands B.V.

Strawinskylaan 3051, 1077 ZX Amsterdam, Noord-Holland, Nederland

EU/1/21/1622

Film-coated tablet

B06AX

15.2.2022

14.2.2022

Saphnelo

anifrolumab

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/21/1623

Concentrate for solution for infusion

L04AA51

15.2.2022

16.2.2022

Kerendia

finerenone

Bayer AG

D-51368 Leverkusen, Deutschland

EU/1/21/1616

Film-coated tablet

C03DA05

17.2.2022

16.2.2022

Sapropterin Dipharma

sapropterin

Dipharma B.V.

Prins Bernhardplein 200, 1097 JB Amsterdam, Nederland

EU/1/21/1620

Powder for oral solution

Soluble tablet

A16AX07

17.2.2022

16.2.2022

Sitagliptin/Metformin hydrochloride Mylan

sitagliptin/metformin hydrochloride

Mylan Ireland Limited

Unit 35/36 Grange Parade, Baldoyle Industrial Estate, Dublin 13, Ireland

EU/1/21/1619

Film-coated tablet

A10BD07

21.2.2022

16.2.2022

Tepmetko

tepotinib

Merck Europe B.V.

Gustav Mahlerplein 102, 1082 MA Amsterdam, Nederland

EU/1/21/1596

Film-coated tablet

L01EX21

17.2.2022

21.2.2022

Ontilyv

opicapone

Bial — Portela & Ca, SA

À Av. da Siderurgia Nacional, 4745-457 S. Mamede do Coronado, Portugal

EU/1/21/1578

Capsule, hard

N04BX04

22.2.2022

—   Modification of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

2.2.2022

Vaxzevria

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/21/1529

2.2.2022

3.2.2022

Clopidogrel Viatris

Viatris Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland

EU/1/09/568

7.2.2022

3.2.2022

DaTSCAN

GE Healthcare B.V.

De Rondom 8, 5612 AP, Eindhoven, Nederland

EU/1/00/135

9.2.2022

3.2.2022

Edarbi

Takeda Pharma A/S

Delta Park 45, 2665 Vallensbæk Strand, Danmark

EU/1/11/734

8.2.2022

3.2.2022

Efavirenz/Emtricitabine/Tenofovir disoproxil Krka

KRKA d d., Novo mesto

Šmarješka cesta 6, 8501 Novo mesto, Slovenija

EU/1/17/1263

9.2.2022

3.2.2022

Nyxoid

Mundipharma Corporation (Ireland) Limited

Millbank House, Arkle Road, Sandyford Industrial Estate, Dublin 18, Ireland

EU/1/17/1238

7.2.2022

3.2.2022

Pregabalin Zentiva

Zentiva, k.s.

U Kabelovny 130, 102 37 Praha 10, Česká republika

EU/1/15/1021

8.2.2022

3.2.2022

Vivanza

Bayer AG

D-51368 Leverkusen, Deutschland

EU/1/03/249

7.2.2022

3.2.2022

Voriconazole Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

EU/1/13/835

4.2.2022

3.2.2022

Xigduo

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/13/900

4.2.2022

4.2.2022

Cialis

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/02/237

8.2.2022

4.2.2022

Comirnaty

BioNTech Manufacturing GmbH

An der Goldgrube 12, 55131 Mainz, Deutschland

EU/1/20/1528

4.2.2022

4.2.2022

Ebixa

H. Lundbeck A/S

Ottiliavej 9, 2500 Valby, Danmark

EU/1/02/219

8.2.2022

4.2.2022

Ebymect

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/15/1051

7.2.2022

4.2.2022

Entacapone Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/10/665

8.2.2022

4.2.2022

HyQvia

Baxalta Innovations GmbH

Industriestraße 67, 1221 Wien, Österreich

EU/1/13/840

7.2.2022

4.2.2022

Iressa

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/09/526

7.2.2022

4.2.2022

Neupro

UCB Pharma S.A.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België

EU/1/05/331

9.2.2022

4.2.2022

Noxafil

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/05/320

8.2.2022

4.2.2022

Plegridy

Biogen Netherlands B.V.

Prins Mauritslaan 13, 1171 LP Badhoevedorp, Nederland

EU/1/14/934

9.2.2022

4.2.2022

Revolade

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/10/612

7.2.2022

4.2.2022

Roclanda

Santen Oy

Niittyhaankatu 20, 33720 Tampere, Suomi

EU/1/20/1502

10.2.2022

4.2.2022

Sivextro

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/15/991

8.2.2022

4.2.2022

Temozolomide Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona, s/n, Edifici Est 6a planta, 08039 Barcelona, España

EU/1/10/615

9.2.2022

4.2.2022

Vantobra

PARI Pharma GmbH

Moosstraße 3, 82319 Starnberg, Deutschland

EU/1/18/1350

10.2.2022

4.2.2022

Yellox

BAUSCH + LOMB IRELAND LIMITED

3013 Lake Drive Citywest Business Campus Dublin 24, D24PPT3, Ireland

EU/1/11/692

14.2.2022

4.2.2022

Zoledronic acid Hospira

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België

EU/1/12/800

7.2.2022

10.2.2022

Ameluz

Biofrontera Bioscience GmbH

Hemmelrather Weg 201, 51377 Leverkusen, Deutschland

EU/1/11/740

15.2.2022

10.2.2022

Axumin

Blue Earth Diagnostics Ireland Ltd

6th Floor, 2 Grand Canal Square, Dublin 2, Ireland

EU/1/17/1186

15.2.2022

10.2.2022

Cotellic

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/15/1048

14.2.2022

10.2.2022

Nityr

Cycle Pharmaceuticals (Europe) Ltd

70 Sir John Rogerson’s Quay, Dublin 2, Ireland

EU/1/18/1290

15.2.2022

10.2.2022

Wakix

Bioprojet Pharma

9 rue Rameau, 75002 Paris, France

EU/1/15/1068

3.3.2022

14.2.2022

Cubicin

Merck Sharp & Dohme B.V.

Waarderweg 39, 2031 BN Haarlem, Nederland

EU/1/05/328

18.2.2022

14.2.2022

Incruse Ellipta

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/14/922

4.3.2022

14.2.2022

Ivabradine Accord

Accord Healthcare S.L.U.

World Trade Center, Moll de Barcelona s/n, Edifici Est, 6a planta, 08039 Barcelona, España

EU/1/17/1190

15.2.2022

14.2.2022

Spikevax

MODERNA BIOTECH SPAIN, S.L.

Calle Monte Esquinza 30, 28010 Madrid, España

EU/1/20/1507

16.2.2022

14.2.2022

Waylivra

Akcea Therapeutics Ireland Limited

Regus House, Harcourt Centre, Harcourt Road, Dublin 2, Ireland

EU/1/19/1360

21.2.2022

14.2.2022

Xromi

Nova Laboratories Ireland Limited

3rd Floor, Ulysses House, Foley Street, Dublin 1, D01 W2T2, Ireland

EU/1/19/1366

17.2.2022

16.2.2022

AMGLIDIA

AMMTeK

55 rue de Turbigo, 75003 Paris, France

EU/1/18/1279

16.2.2022

16.2.2022

Besponsa

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België

EU/1/17/1200

17.2.2022

16.2.2022

CellCept

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/96/005

17.2.2022

16.2.2022

Deltyba

Otsuka Novel Products GmbH

Erika-Mann-Straße 21, 80636 München, Deutschland

EU/1/13/875

17.2.2022

16.2.2022

Eliquis

Bristol-Myers Squibb/Pfizer EEIG

Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, Ireland

EU/1/11/691

17.2.2022

16.2.2022

ellaOne

Laboratoire HRA Pharma

200 avenue de Paris, 92320 Chatillon, France

EU/1/09/522

23.2.2022

16.2.2022

Envarsus

Chiesi Farmaceutici S.p.A.

Via Palermo 26/A, 43122 Parma, Italia

EU/1/14/935

21.2.2022

16.2.2022

Febuxostat Mylan

Mylan Pharmaceuticals Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, DUBLIN, Ireland

EU/1/17/1194

17.2.2022

16.2.2022

JEMPERLI

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/21/1538

17.2.2022

16.2.2022

Laventair Ellipta

GlaxoSmithKline (Ireland) Limited

12 Riverwalk, Citywest Business Campus, Dublin 24, Ireland

EU/1/14/899

4.3.2022

16.2.2022

Mayzent

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/19/1414

17.2.2022

16.2.2022

Modigraf

Astellas Pharma Europe B.V.

Sylviusweg 62, 2333 BE Leiden, Nederland

EU/1/09/523

17.2.2022

16.2.2022

Myclausen

Passauer Pharma GmbH

Eiderstedter Weg 3, 14129 Berlin, Deutschland

EU/1/10/647

17.2.2022

16.2.2022

Pemazyre

Incyte Biosciences Distribution B.V.

Paasheuvelweg 25, 1105 BP Amsterdam, Nederland

EU/1/21/1535

21.2.2022

16.2.2022

Pregabalin Sandoz

Sandoz GmbH

Biochemiestrasse 10, 6250 Kundl, Österreich

EU/1/15/1011

21.2.2022

16.2.2022

Riximyo

Sandoz GmbH

Biochemiestrasse 10, 6250 Kundl, Österreich

EU/1/17/1184

17.2.2022

16.2.2022

Temybric Ellipta

GlaxoSmithKline Trading Services Limited

Riverwalk 12, Citywest Business Campus, Dublin 24, Ireland

EU/1/19/1378

4.3.2022

16.2.2022

Yuflyma

Celltrion Healthcare Hungary Kft.

Váci út 1-3. WestEnd Office Building B torony, 1062 Budapest, Magyarország

EU/1/20/1513

2.3.2022

16.2.2022

Zykadia

Novartis Europharm Limited

Vista Building, Elm Park, Merrion Road, Dublin 4, Ireland

EU/1/15/999

17.2.2022

17.2.2022

Advagraf

Astellas Pharma Europe B.V.

Sylviusweg 62, 2333 BE Leiden, Nederland

EU/1/07/387

21.2.2022

17.2.2022

Avonex

Biogen Netherlands B.V.

Prins Mauritslaan 13, 1171 LP Badhoevedorp, Nederland

EU/1/97/033

23.2.2022

17.2.2022

Mycophenolate mofetil Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/07/439

18.2.2022

17.2.2022

Myfenax

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/07/438

21.2.2022

17.2.2022

Nexium Control

GlaxoSmithKline Dungarvan Limited

Dungarvan, Co. Waterford, Ireland

EU/1/13/860

24.2.2022

18.2.2022

Tarceva

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/05/311

21.2.2022

18.2.2022

Zelboraf

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/12/751

21.2.2022

21.2.2022

Clopidogrel Taw Pharma

Taw Pharma (Ireland) Limited

104 Lower Baggot Street, Dublin 2, Ireland

EU/1/09/559

22.2.2022

21.2.2022

Jardiance

Boehringer Ingelheim International GmbH

Binger Straße 173, 55216 Ingelheim am Rhein, Deutschland

EU/1/14/930

25.2.2022

21.2.2022

Ogivri

Viatris Limited

Damastown Industrial Park, Mulhuddart, Dublin 15, Ireland

EU/1/18/1341

23.2.2022

21.2.2022

Refixia

Novo Nordisk A/S

Novo Allé, 2880 Bagsværd, Danmark

EU/1/17/1193

24.2.2022

21.2.2022

Skilarence

Almirall, S.A.

Ronda General Mitre, 151, 08022 Barcelona, España

EU/1/17/1201

23.2.2022

23.2.2022

Tecentriq

Roche Registration GmbH

Emil-Barell-Strasse 1, 79639 Grenzach-Wyhlen, Deutschland

EU/1/17/1220

25.2.2022

24.2.2022

ADVATE

Takeda Manufacturing Austria AG

Industriestraße 67, 1221 Wien, Österreich

EU/1/03/271

28.2.2022

24.2.2022

Bortezomib Hospira

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België

EU/1/16/1114

25.2.2022

24.2.2022

Briviact

UCB Pharma S.A.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België

EU/1/15/1073

25.2.2022

24.2.2022

Irbesartan Teva

Teva B.V.

Swensweg 5, 2031 GA Haarlem, Nederland

EU/1/09/576

28.2.2022

24.2.2022

JEVTANA

Sanofi-Aventis groupe

54 rue La Boétie, 75008 Paris, France

EU/1/11/676

28.2.2022

24.2.2022

Lacosamide UCB

UCB Pharma S.A.

Allée de la Recherche 60, 1070 Bruxelles, Belgique/Researchdreef 60, 1070 Brussel, België

EU/1/19/1383

25.2.2022

24.2.2022

Rixathon

Sandoz GmbH

Biochemiestrasse 10, 6250 Kundl, Österreich

EU/1/17/1185

25.2.2022

24.2.2022

Senshio

Shionogi B.V.

Kingsfordweg 151, 1043 GR Amsterdam, Nederland

EU/1/14/978

25.2.2022

28.2.2022

Comirnaty

BioNTech Manufacturing GmbH

An der Goldgrube 12, 55131 Mainz, Deutschland

EU/1/20/1528

28.2.2022

28.2.2022

Imfinzi

AstraZeneca AB

151 85 Södertälje, Sverige

EU/1/18/1322

2.3.2022

28.2.2022

Nimenrix

Pfizer Europe MA EEIG

Boulevard de la Plaine 17, 1050 Bruxelles, Belgique/Pleinlaan 17, 1050 Brussel, België

EU/1/12/767

1.3.2022

28.2.2022

Retsevmo

Eli Lilly Nederland B.V.

Papendorpseweg 83, 3528 BJ Utrecht, Nederland

EU/1/20/1527

2.3.2022

28.2.2022

Xagrid

Takeda Pharmaceuticals International AG Ireland Branch

50-58 Baggot Street Lower, Block 3 Miesian Plaza, Dublin 2, Co Dublin, D02 Y754, Ireland

EU/1/04/295

1.3.2022

—   Withdrawal of a marketing authorisation (Article 13 of Regulation (EC) No 726/2004 of the European Parliament and of the Council)

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

3.2.2022

Vivanza

Bayer AG

D-51368 Leverkusen, Deutschland

EU/1/03/249

7.2.2022

—   Modification of a marketing authorisation (Article 38 of Regulation (EC) No 726/2004 of the European Parliament and of the Council): Accepted

Date of the decision

Name of the medicinal product

Holder of the marketing authorisation

Number of the entry in the Community Register

Date of notification

1.2.2022

Bravecto

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/13/158

3.2.2022

1.2.2022

Mirataz

Dechra Regulatory B.V.

Handelsweg 25, 5531 AE Bladel, Nederland

EU/2/19/247

2.2.2022

8.2.2022

Exzolt

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/17/212

9.2.2022

8.2.2022

Zulvac 8 Ovis

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/09/104

9.2.2022

10.2.2022

Draxxin

Zoetis Belgium S.A.

rue Laid Burniat 1, 1348 Louvain-la-Neuve, Belgique

EU/2/03/041

16.2.2022

10.2.2022

Nobilis IB 4-91

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/98/006

14.2.2022

10.2.2022

Onsior

Elanco GmbH

Heinz-Lohmann-Straße 4, 27472 Cuxhaven, Deutschland

EU/2/08/089

11.2.2022

28.2.2022

Innovax-ND-IBD

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/17/213

2.3.2022

28.2.2022

Innovax-ND-ILT

Intervet International B.V.

Wim de Körverstraat 35, 5831 AN Boxmeer, Nederland

EU/2/20/256

2.3.2022

Anyone wishing to consult the public assessment report on the medicinal products in question and the decisions relating thereto is invited to contact:

European Medicines Agency

Domenico Scarlattilaan 6

1083 HS Amsterdam

NETHERLANDS

(1)  OJ L 136, 30.4.2004, p. 1.